These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12461824)

  • 1. Molecular recognition by SH2 domains.
    Bradshaw JM; Waksman G
    Adv Protein Chem; 2002; 61():161-210. PubMed ID: 12461824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.
    Ladbury JE; Hensmann M; Panayotou G; Campbell ID
    Biochemistry; 1996 Aug; 35(34):11062-9. PubMed ID: 8780508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a large family of superbinding bacterial SH2 domains.
    Kaneko T; Stogios PJ; Ruan X; Voss C; Evdokimova E; Skarina T; Chung A; Liu X; Li L; Savchenko A; Ensminger AW; Li SS
    Nat Commun; 2018 Oct; 9(1):4549. PubMed ID: 30382091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 Domain Binding: Diverse FLVRs of Partnership.
    Jaber Chehayeb R; Boggon TJ
    Front Endocrinol (Lausanne); 2020; 11():575220. PubMed ID: 33042028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.
    Jin LL; Wybenga-Groot LE; Tong J; Taylor P; Minden MD; Trudel S; McGlade CJ; Moran MF
    Mol Cell Proteomics; 2015 Mar; 14(3):695-706. PubMed ID: 25587033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
    Ayrapetov MK; Wang YH; Lin X; Gu X; Parang K; Sun G
    J Biol Chem; 2006 Aug; 281(33):23776-84. PubMed ID: 16790421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
    Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
    J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superbinder SH2 domains act as antagonists of cell signaling.
    Kaneko T; Huang H; Cao X; Li X; Li C; Voss C; Sidhu SS; Li SS
    Sci Signal; 2012 Sep; 5(243):ra68. PubMed ID: 23012655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.